Table 1.
Baseline and post-treatment demographic, anthropometric, and biochemical characteristics of patients with thyroid dysfunction
| Total | Hypothyroid patients | Hyperthyroid patients | p | |
|---|---|---|---|---|
| N | 34 | 17 | 17 | |
| Gender | 28 female (82.4%) | 12 female (70.6%) | 16 female (94.1%) | 0.175 |
| Age | 53.4±20.4 | 55.8±18.7 | 50.3±2 2.4 | 0.386 |
| Height (cm) | 161.82±0.08 | 157.53±0.07 | 0.086 | |
| Baseline weight (kg) | 70.93±10.06 | 65.45±11.64 | 0.152 | |
| Final weight (kg) | 68.68±10.14 | 68.37±12.80 | 0.938 | |
| Baseline BMI (kg/m2) | 27.07±3.22 | 26.39±4.44 | 0.609 | |
| Final BMI (kg/m2) | 26.22±3.36 | 27.57±4.98 | 0.361 | |
| Baseline TSH levels | 23.99±26.35 | 0.03±0.02 | 0.000 | |
| Final TSH levels | 3.27±1.53 | 2.98±1.45 | 0.576 | |
| Baseline T4 levels | 0.67±0.17 | 1.58±0.58 | 0.000 | |
| Final T4 levels | 0.91±0.12 | 0.73±0.23 | 0.009 | |
| Thyroid autoimmunity ATPO TSHrAb |
19 (55.9%) | 8 (47.1%) 8 (47.1%) |
11 (64.7%) 2 (11.7%) 9 (52.9%) |
0.300 |
Notes: TSH: Thyrotropin. Normal range: 0.34–5.6 µU/mL. T4: thyroxine. Normal range: 0.54–1.24 µU/mL. ATPO: anti-thyroperoxidase antibodies. TSHr Ab: Anti TSH receptors antibodies.
Abbreviations: BMI, body mass index; FT4, free thyroxine.